Paper
22 July 2019 Ceruloplasmin: a potential carrier of photosensitizers for photodynamic therapy of tumors
Anna G. Gyulkhandanyan, Anna A. Zakoyana, Aram G. Gyulkhandanyan, Marina V. Parkhots, Boris M. Dzhagarov, Ekaterina N. Lazareva, Valery V. Tuchin, Grigor V. Gyulkhandanyana
Author Affiliations +
Abstract
The relevance and importance of the development of new areas of tumor therapy is defined in connection with a strong increase in the level of oncological diseases. The latest global cancer data indicates a high mortality rate: the incidence of cancer increases to 18.1 million new cases and 9.6 million cancer deaths in 2018. Advances in nanostructures and nanotechnologies at the molecular scale in future can revolutionize several aspects of the diagnosis and treatment of body tumors. Search of highly specific and highly effective new therapeutic compounds is one of the most important directions in treatment of oncological diseases by noninvasive way. Currently, in clinics method of photodynamic therapy (PDT) of tumors based on photosensitizers (PSs) and light irradiation is widely used. At its application, the cancer cells are unable to develop resistance to such method of destruction.
© (2019) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Anna G. Gyulkhandanyan, Anna A. Zakoyana, Aram G. Gyulkhandanyan, Marina V. Parkhots, Boris M. Dzhagarov, Ekaterina N. Lazareva, Valery V. Tuchin, and Grigor V. Gyulkhandanyana "Ceruloplasmin: a potential carrier of photosensitizers for photodynamic therapy of tumors", Proc. SPIE 11079, Medical Laser Applications and Laser-Tissue Interactions IX, 110791T (22 July 2019); https://doi.org/10.1117/12.2527568
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Photodynamic therapy

Proteins

Molecules

Tumors

Cancer

Blood

Absorption

Back to Top